SCR-LIP-000355 · Claim · machine-readable JSON →

In 511 lipedema patients, PHQ-9 averaged 10.84±6.39 with 54% at risk of moderate-to-severe depression, WHOQOL-BREF global score averaged 60.5±16.02 (lowest in physical 54.54 and psychological 51.91 domains), and quality-of-life impairment correlated with disease stage (r=0.55, p<0.001) and inversely with depression score (r=-0.775, p<0.0001).

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
2 source(s)
Dates
2026-05-31 → 2026-06-12

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

20222023Characteristics and Patient Reported Outcome Measures in Lipedema Patients—Establishing a Baseline for Treatment Evaluation in a High-Volume Center — Hamatschek et al. (2022) · consistentUnderstanding the Vicious Circle of Pain, Physical Activity, and Mental Health in Lipedema Patients – a Response Surface Analysis — Aitzetmüller-Klietz et al. (2023) · consistent

Evidence (2)

Context (PECO)

Populationwomen with lipedema (n=511)
Conditionlipedema
Exposurelipedema disease stage and depression severity
OutcomePHQ-9 depression score and WHOQOL-BREF quality of life
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log